Suppr超能文献

临床和社会心理因素对银屑病局部治疗依从性的影响

Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis.

作者信息

Teixeira Ana, Teixeira Maribel, Gaio Rita, Torres Tiago, Magina Sofia, Dinis Maria Alzira Pimenta, Sousa-Lobo José, Almeida Isabel, Peixoto Miguel, Almeida Vera

机构信息

Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.

UCIBIO-Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal.

出版信息

Healthcare (Basel). 2024 Apr 12;12(8):822. doi: 10.3390/healthcare12080822.

Abstract

(1) Background: Psoriasis is a common chronic inflammatory skin disease with different manifestations, affecting the quality of life at social, emotional, and professional dimensions and requiring long-term treatment. This study aimed to investigate the effect of psychosocial and clinical factors on adherence to topical treatment in psoriasis. (2) Methods: Self-reported measures and weighing the medicines were used to assess adherence. Psychopathological symptoms were measured using the Brief Symptoms Inventory (BSI). Social and clinical factors were assessed by a sociodemographic and clinical questionnaire. Adherence to treatment with topical medication was assessed using a sample of 102 psoriasis patients. (3) Results: The explanatory models of adherence to topical treatment in psoriasis translated into positive associations between adherence and the education level (higher education) ( = 0.03; φ = 0.23), the single-family household ( = 0.01; φ = 0.44), active employment status ( = 0.05; φ = -0.19), familiar history of psoriasis ( = 0.04; φ = -0.21), and the presence of obsessive-compulsive symptoms ( = 0.01; = 0.29). (4) Conclusions: In patients who present the characteristics identified that influence non-adherence, instructions should be reinforced to increase adherence. The experimental mortality (39.6%) reduced the sample size, representing a limitation of the study.

摘要

(1) 背景:银屑病是一种常见的慢性炎症性皮肤病,有不同的表现形式,在社会、情感和职业层面影响生活质量,需要长期治疗。本研究旨在调查心理社会因素和临床因素对银屑病局部治疗依从性的影响。(2) 方法:采用自我报告措施和药物称重来评估依从性。使用简明症状量表(BSI)测量心理病理症状。通过社会人口统计学和临床问卷评估社会和临床因素。使用102例银屑病患者样本评估局部用药治疗的依从性。(3) 结果:银屑病局部治疗依从性的解释模型转化为依从性与教育水平(高等教育)( = 0.03;φ = 0.23)、单户家庭( = 0.01;φ = 0.44)、在职状态( = 0.05;φ = -0.19)、银屑病家族史( = 0.04;φ = -0.21)以及强迫症状的存在( = 0.01; = 0.29)之间的正相关。(4) 结论:对于具有已确定的影响不依从性特征的患者,应加强指导以提高依从性。实验死亡率(39.6%)减少了样本量,这是本研究的一个局限性。

相似文献

1
Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis.
Healthcare (Basel). 2024 Apr 12;12(8):822. doi: 10.3390/healthcare12080822.
2
Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP).
Am J Clin Dermatol. 2017 Aug;18(4):571-581. doi: 10.1007/s40257-017-0272-2.
3
Adherence to topical treatment in psoriasis: a systematic literature review.
J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:61-7. doi: 10.1111/j.1468-3083.2012.04525.x.
5
Topical treatment adherence and associated factors in patients with psoriasis: A single center, cross-sectional study.
Dermatol Ther. 2022 Jul;35(7):e15547. doi: 10.1111/dth.15547. Epub 2022 May 11.
6
Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals.
Dermatol Ther (Heidelb). 2021 Dec;11(6):2057-2075. doi: 10.1007/s13555-021-00620-x. Epub 2021 Oct 14.
8
Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment.
J Dermatol Sci. 2016 May;82(2):63-8. doi: 10.1016/j.jdermsci.2016.02.008. Epub 2016 Feb 18.
10
Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
J Eur Acad Dermatol Venereol. 2014 May;28 Suppl 2:4-9. doi: 10.1111/jdv.12445.

本文引用的文献

2
The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review.
Arch Dermatol Res. 2023 May;315(4):699-706. doi: 10.1007/s00403-022-02420-5. Epub 2022 Nov 6.
3
Health literacy and medication adherence in psoriasis patients: a survey in Iran.
BMC Prim Care. 2022 May 10;23(1):113. doi: 10.1186/s12875-022-01719-6.
5
Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis.
Pharmaceutics. 2021 Sep 23;13(10):1539. doi: 10.3390/pharmaceutics13101539.
7
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.
JAMA. 2020 May 19;323(19):1945-1960. doi: 10.1001/jama.2020.4006.
8
Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life.
J Dermatolog Treat. 2020 Aug;31(5):470-475. doi: 10.1080/09546634.2020.1746734. Epub 2020 Apr 13.
9
Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council.
J Am Acad Dermatol. 2020 Jan;82(1):117-122. doi: 10.1016/j.jaad.2019.08.026. Epub 2019 Aug 16.
10
Strategies to reduce stigma related to visible chronic skin diseases: a systematic review.
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2029-2038. doi: 10.1111/jdv.15734. Epub 2019 Aug 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验